189 related articles for article (PubMed ID: 27279060)
1. Common therapeutic strategies for prion and Alzheimer's diseases.
Elezgarai SR; Biasini E
Biol Chem; 2016 Nov; 397(11):1115-1124. PubMed ID: 27279060
[TBL] [Abstract][Full Text] [Related]
2. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
Iraci N; Stincardini C; Barreca ML; Biasini E
Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
[TBL] [Abstract][Full Text] [Related]
3. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
Béland M; Roucou X
Prion; 2014; 8(1):106-10. PubMed ID: 24335160
[TBL] [Abstract][Full Text] [Related]
4. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
5. Prion and TNFα: TAC(E)it agreement between the prion protein and cell signaling.
Stella R; Massimino ML; Sorgato MC; Bertoli A
Cell Cycle; 2010 Dec; 9(23):4616-21. PubMed ID: 21099358
[TBL] [Abstract][Full Text] [Related]
6. Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives.
Vincent B; Cisse MA; Sunyach C; Guillot-Sestier MV; Checler F
Curr Alzheimer Res; 2008 Apr; 5(2):202-11. PubMed ID: 18393805
[TBL] [Abstract][Full Text] [Related]
7. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
8. Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein.
Sakudo A; Ikuta K
Protein Pept Lett; 2009; 16(3):217-29. PubMed ID: 19275734
[TBL] [Abstract][Full Text] [Related]
9. Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function.
Leighton PL; Allison WT
J Alzheimers Dis; 2016 Jul; 54(1):3-29. PubMed ID: 27392869
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
11. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators.
Checler F; Vincent B
Trends Neurosci; 2002 Dec; 25(12):616-20. PubMed ID: 12446128
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches for prion and Alzheimer's diseases.
Wisniewski T; Sigurdsson EM
FEBS J; 2007 Aug; 274(15):3784-98. PubMed ID: 17617224
[TBL] [Abstract][Full Text] [Related]
14. Novel regulators of PrP
Colini Baldeschi A; Vanni S; Zattoni M; Legname G
Expert Opin Ther Targets; 2020 Aug; 24(8):759-776. PubMed ID: 32631090
[TBL] [Abstract][Full Text] [Related]
15. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
16. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
17. Almost a century of prion protein(s): From pathology to physiology, and back to pathology.
Peggion C; Bertoli A; Sorgato MC
Biochem Biophys Res Commun; 2017 Feb; 483(4):1148-1155. PubMed ID: 27581199
[TBL] [Abstract][Full Text] [Related]
18. Translational Research in Alzheimer's and Prion Diseases.
Di Fede G; Giaccone G; Salmona M; Tagliavini F
J Alzheimers Dis; 2018; 62(3):1247-1259. PubMed ID: 29172000
[TBL] [Abstract][Full Text] [Related]
19. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Prasad KN; Bondy SC
Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
[TBL] [Abstract][Full Text] [Related]
20. Prions, prionoids and protein misfolding disorders.
Scheckel C; Aguzzi A
Nat Rev Genet; 2018 Jul; 19(7):405-418. PubMed ID: 29713012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]